Metabolic health
Semaglutide: Uses, Side Effects and Safety
Glucagon-like peptide-1 (GLP-1) receptor agonist; prescription medicine.
Overview
Semaglutide is a peptide-based medicine that acts at the GLP-1 receptor. Different semaglutide products have different labeled uses, formulations, and instructions.
How it works
It activates the GLP-1 receptor. The physiological effects and approved uses depend on the specific product and its current prescribing information.
Uses described in the source
The U.S. Wegovy label covers specific indications, including chronic weight management for eligible people and certain cardiovascular-risk and liver-disease uses. This is not a statement that every semaglutide product has those indications.
Evidence
Strong human evidence for product- and indication-specific FDA-labeled uses
Regulatory status
The cited Wegovy label is a U.S. FDA label for specified uses. It does not establish approval or availability in Colombia, or availability through YouMedicine.
Safety
The label includes a boxed warning about thyroid C-cell tumors observed in rodents; human relevance is unknown. It contraindicates use for people with a personal or family history of medullary thyroid carcinoma or MEN 2. Gastrointestinal effects and other important warnings are described in the current product label.
YouMedicine availability
Educational listing only. YouMedicine availability has not been confirmed.
Sources
A product label is not an individual recommendation. Do not use this summary to choose a product, dose, or source; consult a licensed clinician and the current label.